New Clinical Trials for Breast Cancer
 The high visibility of breast cancer through things like the pink ribbon campaigns and breast cancer awareness month has resulted in a lot of focus on developing better drugs for breast cancer. Breast cancer clinical research has improved treatments over the past few decades. These treatments are continually being tested and reviewed. There is still a large need for breast cancer clinical studies.
The high visibility of breast cancer through things like the pink ribbon campaigns and breast cancer awareness month has resulted in a lot of focus on developing better drugs for breast cancer. Breast cancer clinical research has improved treatments over the past few decades. These treatments are continually being tested and reviewed. There is still a large need for breast cancer clinical studies.
(If you are interested in learning more about breast cancer, check these pages out: Breast Cancer Signs & Symptoms)
If you are a survivor of breast cancer or are currently dealing with breast cancer, you may be eligible to take part in one of a current breast cancer clinical trial. Please review the list and contact us if you are interested. As always, participation in clinical trials is at no cost to you.
What is Breast Cancer?
Breast cancer occurs when cancer cells form in either the milk ducts or lobules of breast tissue. It is the most common non-skin cancer found in women and accounts for approximately 10% of all cancer in women. Breast cancer is classified by stages. Stage 0 is the earliest and most easily treated stage while stage 4 is the most advanced and dangerous stage. Breast cancer is often first detected when a woman feels a lump in her breast. She may also notice changes in the look, feel or color of her breasts. Frequent mammograms also often find the first signs of breast cancer. Factors that affect someone’s chances of developing breast cancer include sex, age, hormones, race, diet, and exercise.
Breast Cancer Treatments
With today’s modern medicine and technology, breast cancer treatments most often include a combination of surgery, drugs (hormonal and chemotherapy) and radiation. Surgery removes most of the cancer while radiation kills surrounding cells that may have been missed during surgery. Higher risk breast cancers include those that have spread to the lymph nodes in the armpits. These are treated with cyclophosphamide plus doxorubinin (CA). This treatment is effective, but has bad side effects because it also causes damage to normal cells. Hormone blocking therapy is another treatment for breast cancer. This blocks the estrogen that some cancers need to grow. You can also learn more at PubMed Health.
					
					We've found
					21,509 Breast Cancer				
					clinical trials				
				
			
		
							
  	
	Oncology, Reproductive Clinical Trial
	Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
		Status: Enrolling	
	
	
			Updated: 7/7/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
	Eligibility Screening and Tissue Procurement for the NIH Intramural Research Program Clinical Protocols
		Status: Enrolling,
							Phase
  
							
  	
	Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
	Eligibility Screening and Tissue Procurement for the NIH Intramural Research Program Clinical Protocols
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Collection of Blood From Patients With Cancer
		Status: Enrolling,
							Phase
  
							
  	
	Oncology Clinical Trial
	Collection of Blood From Patients With Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling	
	
	
			Updated: 4/10/2010	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling	
	
	
			Updated: 4/10/2010	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling	
	
	
			Updated: 4/10/2010	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer
		Status: Enrolling	
	
	
			Updated: 4/10/2010	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Protocol for Women at Increased Risk of Developing Breast Cancer
		Status: Enrolling,
							Phase
  
							
  	
	Breast Cancer Clinical Trial
	Protocol for Women at Increased Risk of Developing Breast Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Musculoskeletal, Oncology, Other Clinical Trial
	Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors
		Status: Enrolling
  
							
  	
	Musculoskeletal, Oncology, Other Clinical Trial
	Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors
		Status: Enrolling	
	
	
			Updated: 9/16/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Stage I Breast Cancer Clinical Trial
	Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Stage I Breast Cancer Clinical Trial
	Partial Breast Radiation to the Lumpectomy Cavity With IMRT in Elderly Women
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 6/13/2006	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Neoplasms, Breast Clinical Trial
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 4/4/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Chemotherapy and Bevacizumab in Treating Women With Invasive Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Chemotherapy and Bevacizumab in Treating Women With Invasive Breast Cancer
		Status: Enrolling	
	
	
			Updated: 2/6/2009	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Neoplasms Clinical Trial
	Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Breast Neoplasms Clinical Trial
	Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 2/12/2007	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
		Status: Enrolling,
							Phase
  
							
  	
	Breast Cancer Clinical Trial
	Changes in Breast Density and Breast Cancer Risk in Women With Breast Cancer and in Healthy Women
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
		Status: Enrolling	
	
	
			Updated: 7/11/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
		Status: Enrolling	
	
	
			Updated: 7/11/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Breast Cancer Clinical Trial
	Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 10/23/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
		Status: Enrolling,
							Phase
																				 I,  II
  
							
  	
	Oncology Clinical Trial
	Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 10/16/2010	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling	
	
	
			Updated: 11/30/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling	
	
	
			Updated: 11/30/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling	
	
	
			Updated: 11/30/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling	
	
	
			Updated: 11/30/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling	
	
	
			Updated: 11/30/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling	
	
	
			Updated: 11/30/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling
  
							
  	
	Oncology Clinical Trial
	A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
		Status: Enrolling	
	
	
			Updated: 11/30/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
		Status: Enrolling	
	
	
			Updated: 1/9/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Doxorubicin Hydrochloride Liposome in Treating Women With Ductal Carcinoma in Situ Undergoing Surgery
		Status: Enrolling	
	
	
			Updated: 1/9/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/24/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/24/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/24/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/24/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Contrast-Enhanced MRI in Women With Ductal Breast Carcinoma in Situ and in Healthy Volunteers
		Status: Enrolling	
	
	
			Updated: 12/15/2014	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
		Status: Enrolling,
							Phase
  
							
  	
	Breast Cancer Clinical Trial
	Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Oncology, Psychiatry / Psychology Clinical Trial
	Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
		Status: Enrolling
  
							
  	
	Oncology, Psychiatry / Psychology Clinical Trial
	Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer
		Status: Enrolling	
	
	
			Updated: 1/5/2011	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.
		Status: Enrolling,
							Phase
  
							
  	
	Breast Cancer Clinical Trial
	Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S.
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling
  
							
  	
	Breast Cancer Clinical Trial
	Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer
		Status: Enrolling	
	
	
			Updated: 9/20/2012	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
Updated: 7/7/2015
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 4/10/2010
 
  Updated: 4/10/2010
 
  Updated: 4/10/2010
 
  Updated: 4/10/2010
 
  Updated: 12/31/1969
 
  Updated: 9/16/2013
 
  Updated: 6/13/2006
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 4/4/2016
 
  Updated: 2/6/2009
 
  Updated: 2/12/2007
 
  Updated: 12/31/1969
 
  Updated: 7/11/2012
 
  Updated: 7/11/2012
 
  Updated: 10/23/2014
 
  Updated: 10/16/2010
 
  Updated: 11/30/2015
 
  Updated: 11/30/2015
 
  Updated: 11/30/2015
 
  Updated: 11/30/2015
 
  Updated: 11/30/2015
 
  Updated: 11/30/2015
 
  Updated: 11/30/2015
 
  Updated: 1/9/2014
 
  Updated: 1/9/2014
 
  Updated: 9/24/2013
 
  Updated: 9/24/2013
 
  Updated: 9/24/2013
 
  Updated: 9/24/2013
 
  Updated: 12/15/2014
 
  Updated: 12/31/1969
 
  Updated: 1/5/2011
 
  Updated: 12/31/1969
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
 
  Updated: 9/20/2012
